Comparison of perioperative practices for placement of central venous access devices (CVAD) in children with haemophilia

1 Coppola A, Di Capua M, Di Minno MN, et al. Treatment of hemophilia: a review of current advances and ongoing issues. J Blood Med 2010; 1: 183–95. doi: 10.2147/JBM.S6885. CoppolaA Di CapuaM Di MinnoMN Treatment of hemophilia: a review of current advances and ongoing issues J Blood Med 2010 1 183 95 10.2147/JBM.S6885 326231622282697 Open DOISearch in Google Scholar

2 Iorio A, Marchesini E, Marcucci M, Stobart K, Chan AK. Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B. Cochrane Database Syst Rev 2011; (9): Cd003429. doi: 10.1002/14651858.cd003429.pub4. IorioA MarchesiniE MarcucciM StobartK ChanAK Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B Cochrane Database Syst Rev 2011 9 Cd003429 10.1002/14651858.cd003429.pub4 Open DOISearch in Google Scholar

3 Manco-Johnson MJ, Abshire TC, Shapiro AD, et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med 2007; 357(6): 535–44. doi: 10.1056/NEJMoa067659. Manco-JohnsonMJ AbshireTC ShapiroAD Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia N Engl J Med 2007 357 6 535 44 10.1056/NEJMoa067659 17687129 Open DOISearch in Google Scholar

4 Langley AR, Stain AM, Chan A, et al. Experience with central venous access devices (CVADs) in the Canadian hemophilia primary prophylaxis study (CHPS). Haemophilia 2015; 21(4): 469–76. doi: 10.1111/hae.12713. LangleyAR StainAM ChanA Experience with central venous access devices (CVADs) in the Canadian hemophilia primary prophylaxis study (CHPS) Haemophilia 2015 21 4 469 76 10.1111/hae.12713 26104147 Open DOISearch in Google Scholar

5 Rodriguez V, Mancuso ME, Warad D, et al. Central venous access device (CVAD) complications in Haemophilia with inhibitors undergoing immune tolerance induction: Lessons from the international immune tolerance study. Haemophilia 2015; 21(5): e369–e74. doi: 10.1111/hae.12740. RodriguezV MancusoME WaradD Central venous access device (CVAD) complications in Haemophilia with inhibitors undergoing immune tolerance induction: Lessons from the international immune tolerance study Haemophilia 2015 21 5 e369 e74 10.1111/hae.12740 26178581 Open DOISearch in Google Scholar

6 DiMichele DM, Hoots WK, Pipe SW, Rivard GE, Santagostino E. International workshop on immune tolerance induction: consensus recommendations. Haemophilia 2007; 13 Suppl 1: 1–22. doi: 10.1111/j.1365-2516.2007.01497.x. DiMicheleDM HootsWK PipeSW RivardGE SantagostinoE International workshop on immune tolerance induction: consensus recommendations Haemophilia 2007 13 Suppl 1 1 22 10.1111/j.1365-2516.2007.01497.x 17593277 Open DOISearch in Google Scholar

7 Vepsäläinen K, Lassila R, Arola M, et al. Complications associated with central venous access device in children with haemophilia: a nationwide multicentre study in Finland. Haemophilia 2015; 21(6): 747–53. doi: 10.1111/hae.12665. VepsäläinenK LassilaR ArolaM Complications associated with central venous access device in children with haemophilia: a nationwide multicentre study in Finland Haemophilia 2015 21 6 747 53 10.1111/hae.12665 25832453 Open DOISearch in Google Scholar

8 Valentino LA, Ewenstein B, Navickis RJ, Wilkes MM. Central venous access devices in haemophilia. Haemophilia 2004; 10(2): 134–46. doi: 10.1046/j.1365-2516.2003.00840.x. ValentinoLA EwensteinB NavickisRJ WilkesMM Central venous access devices in haemophilia Haemophilia 2004 10 2 134 46 10.1046/j.1365-2516.2003.00840.x 14962202 Open DOISearch in Google Scholar

9 Ljung R. Central venous catheters in children with haemophilia. Blood Rev 2004; 18(2): 93–100. doi: 10.1016/S0268-960X(03)00043-2. LjungR Central venous catheters in children with haemophilia Blood Rev 2004 18 2 93 100 10.1016/S0268-960X(03)00043-2 15010148 Open DOISearch in Google Scholar

10 Bollard CM, Teague LR, Berry EW, Ockelford PA. The use of central venous catheters (portacaths) in children with haemophilia. Haemophilia 2000; 6(2): 66–70. doi: 10.1046/j.1365-2516.2000.00381.x. BollardCM TeagueLR BerryEW OckelfordPA The use of central venous catheters (portacaths) in children with haemophilia Haemophilia 2000 6 2 66 70 10.1046/j.1365-2516.2000.00381.x 10781190 Open DOISearch in Google Scholar

11 Neunert CE, Miller KL, Journeycake JM, Buchanan GR. Implantable central venous access device procedures in haemophilia patients without an inhibitor: systematic review of the literature and institutional experience. Haemophilia 2008; 14(2): 260–70. doi: 10.1111/j.1365-2516.2007.01605.x. NeunertCE MillerKL JourneycakeJM BuchananGR Implantable central venous access device procedures in haemophilia patients without an inhibitor: systematic review of the literature and institutional experience Haemophilia 2008 14 2 260 70 10.1111/j.1365-2516.2007.01605.x 18179577 Open DOISearch in Google Scholar

12 Srivastava A, Santagostino E, Dougall A, Kitchen S, Sutherland M, Pipe SW, et al. WFH Guidelines for the Management of Hemophilia, 3rd edition. Haemophilia 2020; 26(S6): 1–158. doi: 10.1111/hae.14046. SrivastavaA SantagostinoE DougallA KitchenS SutherlandM PipeSW WFH Guidelines for the Management of Hemophilia, 3rd edition Haemophilia 2020 26 S6 1 158 10.1111/hae.14046 32744769 Open DOISearch in Google Scholar

13 Minna K, Anne M, Beatrice N, Rainer K, Susanna R. Correction of haemostasis can be reduced to four days for CVAD implantation in severe haemophilia A patients: Data from the PedNet study group. Haemophilia 2021; 27(3): 392–7. doi: 10.1111/hae.14231. MinnaK AnneM BeatriceN RainerK SusannaR Correction of haemostasis can be reduced to four days for CVAD implantation in severe haemophilia A patients: Data from the PedNet study group Haemophilia 2021 27 3 392 7 10.1111/hae.14231 33745218 Open DOISearch in Google Scholar

14 Hagglof H, Magnusson M, Petrini P, Frisk T, Ranta S. Perioperative haemostasis in children with haemophilia and inhibitors during central venous catheter surgery: The Karolinska model. Haemophilia 2018; 24(5): e380–e3. doi: 10.1111/hae.13594. HagglofH MagnussonM PetriniP FriskT RantaS Perioperative haemostasis in children with haemophilia and inhibitors during central venous catheter surgery: The Karolinska model Haemophilia 2018 24 5 e380 e3 10.1111/hae.13594 30088320 Open DOISearch in Google Scholar